Public and Patients
- About Us
- Cancer Information
- Clinical Trials
- Events & Outreach
- Make a Gift
- News & Feature Stories
- Survivorship
Researchers and Staff
Cancer Center Update
April 4, 2006
Cancer Center Update is sent to Cancer Center members and staff every Tuesday at 10 a.m. To submit an item for publication, send the information to Sandi Sherman by noon the Friday before publication.
In This Issue:
Professional Education and Seminars
Grant Information & Announcements
There is no seminar today due to the annual meeting of the American Association for Cancer Research.
A peek at next week's seminar:
Role of cell death in modulating tumorigenesis and chemotherapy
Eileen White, Ph.D., Professor. Molecular Biology and Biochemistry, Rutgers University , Associate Director for Basic Science, The Cancer Institute of New Jersey
Host: Ameeta Kelekar, Ph.D.
For a complete schedule,visit
http://www.cancer.umn.edu/page/aboutus/date.html
RECRUITMENT SEMINAR
Thursday, April 6, 2006, 1:30-2:30 p.m., 2-101 NHH
Viral transduction of stem cells for the genetic analysis of mammary development and tumorigenesis
Bryan Welm, Ph.D., Postdoctoral Fellow, University of California , San Francisco
Dr. Welm is a candidate for a faculty position in the Cancer Progression and Metastasis Program, a joint recruitment between the Masonic Cancer Center and the Department of Laboratory Medicine and Pathology.
KUDOS
Congratulations to Cancer Center member Koho Iizuka, M.D., Assistant Professor, Department of Medicine, on his 2006 ASH Scholar Award. Iizuka is one of 15 researchers nationally to receive an award in 2006. He received the Clinical/Translational Junior Faculty award for his proposal “'Masking-self' Hypothesis for NK Cell Tolerance and Graft-Versus-Leukemia.”
MEMBERS IN THE NEWS
Robert Madoff, M.D., professor, Department Surgery, Division of Colon and Rectal Surgery and member of the Masonic Cancer Center's Translational Research Program, wrote a Health Talk & You column on how cancer screening can save lives. It was featured last Friday in the Pilot-Independent which can be accessed on line at walkermn.com.
.
Doug Yee, M.D., Tickle Family Chair in Breast Cancer Research and director of the Masonic Cancer Center 's Breast Cancer Research Program, is featured on the web site of the Office of the Vice-President for Research at the University of Minnesota.
REGISTRATION OPENS FOR CANCER CENTER SPRING POSTER SESSION AND SYMPOSIUM
Online registration is now open for those wishing to present posters or oral presentations on their research at the Seventh Annual Spring Poster Session and Symposium sponsored by the Masonic Cancer Center Core Facilities scheduled for May 18, 2006. The final registrations deadline is April 28. The poster session and symposium will be held from 11 a.m. to 1:30 p.m. with oral presentations from 11 a.m. to noon followed by poster session and lunch from noon to 1:30 p.m. Students, staff, post-docs and PIs are invited to participate by presenting a poster. Visit our web site for the online registration form.
Due to the increasing number (and size!) of posters and the limited amount of display space, we have decided to display the first 35 abstracts/posters that are submitted in the Masonic Cancer Center atrium areas. Other posters will be displayed as space permits in other areas of the Masonic Cancer Center . All abstracts will be printed in the program booklet. For more information, call Susan Collins at 4-0659 or send an email to colli017@umn.edu .
BEYOND THE CURE EDUCATIONAL CONFERENCE SATURDAY, APRIL 8
Parents of cancer survivors, cancer survivors ages 16 and up and professionals who work with childhood cancer survivors are invited to Beyond the Cure, a free educational conference Saturday, April 8 at the McNamara Alumni Center on the University of Minnesota campus. Childhood cancer experts will discuss long-term medical and emotional issues for survivors as well as strategies for living well after cancer. The conference will also include Scott Burton, an author and humorist who tells the tale of his own cancer survivorship with humanity and refreshing honesty.
This event, the first of its kind in Minnesota, is sponsored by the Masonic Cancer Center, along with University of Minnesota Physicians’ Masonic Cancer Clinic; University of Minnesota Medical Center; University of Minnesota Children’s Hospital, Fairview; Children’s Hospitals and Clinics of Minnesota; and Care Partners of the Children’s Cancer Research Fund. Beyond the Cure is a program of The National Children’s Cancer Society. For a complete schedule and registration information, visit the Masonic Cancer Center Web site.
WINE EVENT AT COSMOS APRIL 12, 2006 WILL BENEFIT THE CHILDREN'S CANCER RESEARCH FUND
You are cordially invited to attend a special Wine Makers Dinner at the four-diamond-rated Cosmos restaurant in the Graves 601 Hotel, 601 First Avenue N. in downtown Minneapolis on April 12, 2006. The event is limited to 80 people; a portion of the proceeds will benefit the Children's Cancer Research Fund. The purpose of the event is to showcase the California wines of O'Shaughnessy Winery and Capiaux Vineyards, which will be pared with a special five-course menu developed by Cosmos' award-winning executive chef, Seth Bixby Daugherty. Chef Daugherty will host the event, introducing each course and commenting on how the food was created to compliment the featured wines. Marshall , Minn.-born Betty O'Shaughnessy of O'Shaughnessy Winery will also be on hand to discuss the wines and answer questions. The event schedule includes a reception with cocktails and hors d'oeuvres from 6-7 p.m. and dinner from 7-9 p.m. The cost is $150 per person (a portion is tax deductible). For more information and to RSVP, please call Cosmos at 612-312-1168 and let them know you are with Children's Cancer Research Fund.
SEEKING RECOGNITION AWARD NOMINATIONS
We are currently accepting nominations for the Masonic Cancer Center 's recognition award honoring outstanding contributors in Outreach and Administration. Outreach and Administration staff, as well as other staff and faculty contributing to the Masonic Cancer Center in these areas, are eligible for this award. Nominees do not need to be Cancer Center employees.
To submit a nomination online, go to the Masonic Cancer Center web site.
Electronic or hard copies of the form may also be requested from
cchr@umn.edu. A recognition event will be announced later this month.
U OF M CANCER CENTER INVITES PUBLIC TO ASK EXPERTS ABOUT SKIN CANCER, EFFECTS OF SECONDHAND SMOKE
Shedding light on the growing problem of skin cancer and discussing what the big deal is about public smoking will be the topics for the spring 2006 Cancer U: Ask The Experts programs, sponsored by the Masonic Cancer Center.
The first program, “Skin Cancer: Shedding Light on a Growing Problem,” will be held from 9-11 a.m. on Saturday, April 29, at the Radisson University Hotel, 615 Washington Ave., S.E., in Minneapolis. The second program, “What's the Big Deal about Public Smoking?” will be offered Saturday, May 6, also from 9-11 a.m. at the Radisson University Hotel.
The Masonic Cancer Center sponsors the Cancer U: Ask the Experts series in collaboration with its clinical research and treatment partners: University of Minnesota Physicians and University of Minnesota Medical Center . The programs are an opportunity for interested individuals to get accurate information about cancer from University cancer doctors and researchers. For more information please visit the Masonic Cancer Center web site.
IMMUNOLOGY PROGRAM SEMINAR
Wednesday, April 5, 2006, 1:30-2:30 p.m., 6-160 NHH
Immune reconstitution inflammatory syndrome in Uganda
Paul Bohjanen, M.D., Ph.D., Assistant Professor. Department of Microbiology
Click here for a complete schedule.
CORE CURRICULUM SEMINAR
Friday, April 7, 2006, 10-11 a.m., 450 CCRB
Non-Hodgkins Lymphoma
Bruce Peterson, M.D.
Click here for a complete schedule.
TRANSDISCIPLINARY TOBACCO USE RESEARCH CENTER SEMINAR
Friday, April 7, 2006, 12-1 p.m., 450 CCRB
Pharmacogenetics of Nicotine Addiction Treatment
Neal Benowitz, M.D., Professor of Medicine, Psychiatry and Biopharmaceutical Sciences, University of California , San Francisco
Click here for a complete schedule.
TTURC COURSE
Friday, April 7, 2006, 1:15-2 p.m., 450 CCRB
"How science can inform tobacco policy"
Harry Lando, Ph.D., Department of Epidemiology
Click here for a complete schedule.
CANCER BIOLOGY RESEARCH CLUB
Friday, April 7, 2006, 3:30-4:30 p.m., 450 CCRB
Using the Custom Minnesota SNP Chip to Assess Cancer Risk and Response
Brian Van Ness, Ph.D., Professor, Department of Genetics, Cell Biology and Development
Click here for a complete schedule.
BMT CONFERENCE
Monday, April 10, 2006, 1:15-2:15 p.m., 450 CCRB
Adult UCB transplant
Claudio Brunstein, M.D. , Assistant Professor, Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota
Click to see a complete schedule.
GRANT INFORMATION & ANNOUNCEMENTS
LEUKEMIA RESEARCH FUND ANNOUNCES REQUEST FOR PROPOSALS
Please note there are two deadlines. The first deadline, April 7, 2006, requests a "letter of intent" that states the name of the investigator and the title of the application. This should be e-mailed to Tucker LeBien: lebie001@umn.edu . The second deadline for receipt of completed applications is 4 p.m., May 5, 2006. Applications, should be emailed as a PDF file to Sandi Sherman, sherm019@umn.edu .
The Leukemia Research Fund is once again soliciting proposals for research funding. Applications may be made in two categories:
•Category 1 — Basic: Proposals should focus on the cellular and/or molecular mechanisms that govern the development or progression of cancer, with a priority on leukemia and related diseases. Proposals could include relevant models in developmental biology that provide insight into the development and progression of cancer.
•Category 2 — Translational: Proposals should focus on the development and/or analysis of innovative approaches for treating leukemia and related diseases. Areas could include, but would not be restricted to: gene therapy, tumor targeting, cellular therapy, novel cytotoxic agents, tumor angiogenesis, regulation of apoptosis, or stem cell procurement.
Grants will be awarded effective August 1, 2006 for one year with a second year possible contingent upon adequate progress and availability of funds. Full-time University of Minnesota faculty at the ranks of Assistant Professor, Associate Professor, or Professor are eligible to apply.
Pre-application questions about eligibility and/or the scientific categories should be directed to Tucker LeBien at lebie001@umn.edu or 626-1422. Questions about technical aspects of the application process may be directed to Sandi Sherman at sherm019@umn.edu or 626-0671.
Application instructions and copies of the grant application forms may be accessed at the Masonic Cancer Center's web site.
AMERICAN CANCER SOCIETY INSTITUTIONAL RESEARCH GRANT APPLICATIONS
American Cancer Society Institutional Research Grant applications are being accepted until April 10, 2006. This grant is for assistant professors who have no independent national funding and are engaged in cancer-related research. Cancer-related research includes genetic mechanisms of cancer, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic models and translational research, cancer immunology and immunotherapy. Funding is available up to $20,000. Applications may be obtained by calling 612-626-1926 or sending email to micek003@umn.edu.
2006 CANCER CENTER INTERNAL GRANT PROGRAMS
The Masonic Cancer Center announces the availability of three internal grant programs. The goal of these programs is to foster the development of and provide support for novel research ideas that focus on a problem in cancer. In turn, the Masonic Cancer Center expects that internal funding will lead to nationally peer reviewed funding.
Brainstorm Awards – The objective of the Brainstorm Awards is to foster new interdisciplinary collaborations encompassing novel, hypothesis-driven studies of cancer or a cancer-related topic. The proposed project must be a joint, collaborative effort by at least two Cancer Center members from different programs or different disciplines, and must represent a new collaborative proposal.
Cancer Population Sciences Awards – The objective of the Population Sciences Awards is to foster innovative research in Population Sciences which has the potential to form the basis of future research initiatives. Applicants must be members of the Masonic Cancer Center .
Translational Breast Cancer Research Awards –The objective of the Translational Breast Cancer Research Award is to support research in the biology, prevention, detection, diagnosis, and/or treatment of breast cancer. Applicants must be members of the Masonic Cancer Center .
In prior years, awards have ranged from a minimum of $25,000 to a maximum of $50,000 in direct costs for 1 year. Awards will be made in $25,000 modules. The total funding available for Brainstorm Awards is $100,000 (up to four modules); for the Population Sciences awards, $50,000 (two modules); and for the Breast Cancer Awards, $75,000 (three modules). The application deadline for all three internal grant programs is 4:30 pm on April 28, 2006. All proposals must be hand-delivered to 754 CCRB addressed to the attention of Maggie Thompson, Preaward Services Coordinator. Applicants will be notified of the review outcome by the end of May. Awards will be made for one year, with an anticipated activation date of July 1, 2006. For further information and application instructions, please see the Masonic Cancer Center Web site.
UNDERSTANDING THE EFFECTS OF EMERGING CELLULAR, MOLECULAR, AND GENOMIC TECHNOLOGIES ON CANCER HEALTH CARE DELIVERY (R01)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement
The purpose of this funding opportunity announcement (FOA) is to invite applications for health services research addressing utilization of cellular, molecular, and genetic or genomic (CMG) technologies in cancer care. The studies will assess CMG technologies in relation to: quality of care; organizational barriers and change factors in utilization; cost and cost-effectiveness; disparities in access and efficacy; monitoring of cross-sectional patterns of care and time trends; impact on existing standards of care, and; influence on cancer outcomes such as incidence, progression, mortality, survival, and quality of life. For further information, see the full announcement at Grants.gov.
UNDERSTANDING THE EFFECTS OF EMERGING CELLULAR, MOLECULAR, AND GENOMIC TECHNOLOGIES ON CANCER HEALTH CARE DELIVERY (R21)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement
This FOA runs in parallel with another FOA of identical scientific scope, PA-06-280, which solicits NIH R01 grant applications.
The purpose of this funding opportunity announcement (FOA) is to invite applications for health services research addressing utilization of cellular, molecular, and genetic or genomic (CMG) technologies in cancer care. The studies will assess CMG technologies in relation to: quality of care; organizational barriers and change factors in utilization; cost and cost-effectiveness; disparities in access and efficacy; monitoring of cross-sectional patterns of care and time trends; impact on existing standards of care, and; influence on cancer outcomes such as incidence, progression, mortality, survival, and quality of life. For further information, see the full announcement at Grants.gov.
STEM CELLS AND CANCER (R21)
National Cancer Institute, National Institute on Aging
Application Receipt/Submission Date(s): Multiple dates, see announcement
The Research Objectives section of this announcement will focus on the most recent research on tumor stem cells, because of the importance of these stem cells to understanding tumor biology. However, it should be emphasized that the purpose of this announcement is to encourage research on all aspects of stem cell biology. For further information, see the full announcement at Grants.gov.
DIET-INDUCED CHANGES IN INFLAMMATION AS DETERMINANTS OF COLON CANCER (R21)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement.
The goal of this FOA concept is to foster innovative research that will identify and characterize diet-induced changes in inflammation linked with colon cancer risks. This FOA does not encompass epidemiological studies. The purpose of this initiative is to promote research to: 1) identify and characterize diet-induced changes in anti- and pro-inflammatory mediators that modulate colon cancer risk; 2) define genetic polymorphisms that modify the response to specific bioactive food components with regard to colon cancer inhibition; and 3) unravel the physiological effectiveness of dietary components in terms of concentration, activity, duration of exposure, degree of stability, chemical forms, and binding affinity to receptors in inflammatory colonocytes. For further information, see complete announcement at Grants.gov.
IMMUNOREGULATION OF GASTROINTESTINAL CARCINOGENESIS (R01)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement.
This funding opportunity is intended to promote research that will lead to advances in our understanding of the two opposite roles of the mucosal immune system in gastrointestinal carcinogenesis: (1) in initiating and maintaining inflammation associated with the development of pre-malignant and malignant cancers and (2) in immunoregulatory processes that attenuate inflammation and decrease tumorigenesis.
Grant applications submitted in response to this FOA should be focused on understanding how the unique gastrointestinal microenvironment shapes mucosal responses in the setting of cancer-related inflammatory diseases. For further information, please see the full announcement at Grants.gov.
.
IMMUNOREGULATION OF GASTROINTESTINAL CARCINOGENESIS (R21)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement
This funding opportunity is intended to promote research that will lead to advances in our understanding of the two opposite roles of the mucosal immune system in gastrointestinal carcinogenesis: (1) in initiating and maintaining inflammation associated with the development of pre-malignant and malignant cancers and (2) in immunoregulatory processes that attenuate inflammation and decrease tumorigenesis. For further information, please see the full announcement at Grants.gov.
ETIOLOGY, PREVENTION, AND TREATMENT OF HEPATOCELLULAR CARCINOMA (R21)
National Cancer Institute, National Institute on Alcohol Abuse and Alcoholism, National Institute of Biomedical Imaging and Engineering, National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Date(s): Multiple Dates, see announcement
The NCI, NIDDK, NIBIB, and NIAAA are interested in receiving grant applications that address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC) and development of animal models, novel approaches to prevent this malignancy, and therapeutic or diagnostic studies aimed at establishing reliable prognostic indicators for disease progression and/or minimizing morbidity and mortality associated with this malignancy. Since the main thrust of this FOA is the basic biology, prevention, and treatment of liver cancer, applications solely concerned with population studies and epidemiology are not appropriate for this FOA. For further information, please see the full announcement at Grants.gov.
CORRELATIVE STUDIES WITH SPECIMENS FROM MULTI-SITE TRIALS
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement
The objectives of this funding opportunity are to foster collaborations and interactions between basic researchers, scientists working in private industry, and clinical investigators to perform clinical translational research on promising predictive and prognostic markers. These studies should focus on clinical correlative or mechanistic studies that will be useful for cancer risk assessment, early detection, and prognosis, and the predicting responses to therapy and to prevention interventions. These studies should focus on correlations between biologic features of tissue specimens (collected from the NCI Cooperative Groups or other large multi-institutional clinical trials) and patient outcomes. For further information, please see the full announcement at Grants.gov.
PROTEIN BIOMARKERS OF INFECTION-ASSOCIATED CANCERS (R21)
National Cancer Institute
National Institute of Dental and Craniofacial Research
Application Receipt/Submission Date(s): Multiple dates, see announcement
The long-term goal of this FOA is to encourage the development and utilization of protein profiles in early detection, risk assessment, and prevention of cancer. For example, infection with Hepatitis C and B viruses are major risk factors for hepatocellular cancer, but most infected individuals do not develop cancer. For further information, please see the full announcement at Grants.gov.
EXPLORATORY STUDIES IN CANCER DETECTION, DIAGNOSIS, AND PROGNOSIS (R21)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement.
The major goal of this initiative is to promote the initial evaluation of new molecular or cellular characteristics of pre-malignant cells or tumors or the development of assays that will be useful for cancer detection, diagnosis, and/or prognosis. New biomarkers and laboratory assays are needed for cancer screening and risk assessment, for pathologic characterization of malignant tumors and assessment of disease prognosis, and for prediction and measurement of response to treatments, particularly with novel therapeutic or chemopreventive agents. Investigators are encouraged to pursue new clinical insights and to consider the full array of potentially informative biological characteristics of tumor cells and tissues. For further information, please see the full announcement at Grants.gov.
PILOT STUDIES IN PANCREATIC CANCER (R21)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement
The purpose of this funding opportunity announcement is to promote innovative research across multiple disciplines to better understand the etiology of pancreatic cancer and to promote its early detection, prevention, and treatment. These are short-term awards intended to provide support for pilot projects, testing of new techniques, and/or development of innovative projects that could provide a basis for more extended research. For further information, please see the full nnouncement at Grants.gov.
STUDIES OF THE ECONOMICS OF CANCER PREVENTION, SCREENING, AND CARE (R21)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement
This initiative supports research directed at increasing our understanding of studies of the economics of cancer prevention, screening, and care. Cancer is a heterogeneous chronic disease characterized by innovation in treatment and care approaches. Studies that cover the national population of all ages on an episodic basis fail to capture an adequate sample of cancer patients or the full scope and duration of cancer costs. Studies that focus on a convenience sample of cancer patients in a single health care delivery setting or community can be criticized as lacking external validity. Studies proposed in response to this FOA will be expected to address these issues and propose innovative methods of overcoming these limitations. For further information, please see the full announcement at Grants.gov.
DECISION MAKING IN CANCER: SINGLE-EVENT DECISIONS (R21)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple Dates, see announcement
The purpose of this FOA is to invite applications for research projects that will enhance understanding of human decision-making processes so that individuals can make more informed and satisfying choices regarding their health. The NCI encourages collaborations between basic judgment and decision-making researchers, and applied cancer control researchers that will elucidate single-event decision-making processes at the level of the individual patient or health care provider that are pertinent to cancer prevention, detection, treatment, survivorship, or end-of-life care. For the purpose of this initiative, a single-event decision is defined as a discrete decision made at a specific point in time. For further information, please see the full announcement at Grants.gov.
SMALL GRANTS PROGRAM FOR CANCER EPIDEMIOLOGY (R03)
National Cancer Institute
Application Receipt/Submission Date(s): July 20, 2006; November 20, 2006; March 20, 2007; July 20, 2007; November 20, 2007; March 20, 2008; July 21, 2008; November 21, 2008.
The Division of Cancer Control and Population Sciences (DCCPS) of the National Cancer Institute (NCI) invites Small Grant (R03) applications relating to cancer epidemiology with a primary focus on etiologic cancer research. These are short-term awards intended to provide support for pilot projects, testing of new techniques, or development of innovative projects that could provide a basis for more extended research. The purposes are to support pilot projects, test new techniques, and encourage innovative or high-risk research. For further information, please see the full announcement at Grants.gov.
V FOUNDATION GRANT OPPORTUNITIES
PRE-CLINICAL/CLINICAL RESEARCH
Amount/Duration: $600,000 over a three-year period
Deadline: June 2, 2006
The V Foundation Grant is intended to fund a cancer research project which brings together pre-clinical and clinical investigators for grant consideration. This work must not be currently funded by other mechanisms external to the Masonic Cancer Center. The purpose of these grants is to develop novel approaches to the prevention, detection and treatment of human cancer that requires collaboration of investigators from both the lab and clinic. Ten percent of the grant annually may be used to offset the indirect costs of the project. The project team must have a minimum of two scientists from the same facility and the team must possess basic and clinical research expertise.
The University may submit one application. Preliminary proposals should be 1-2 pages in length and describe why the nominee deserves the award and what research will be performed during the award period. A curriculum vitae should also be included. If there are multiple applicants, the Masonic Cancer Center Executive Committee will name a committee of faculty members who will select the finalist to represent the University. Questions should be addressed to Mark Paller, Assistant Vice President for Research, AHC (palle001@umn.edu). Nominating materials should be sent via e-mail to Mary Sumpmann (sumpm001@umn.edu) before April 21, 2006. Additional information on the V Foundation can be found at their web site.
BASIC RESEARCH
Amount/Duration: A total of $100,000 is given in two yearly installments, funds will be used to offset the direct costs of the research project
Deadline: June 16, 2006
Funding is available to pursue basic research in cancer biology and/or carcinoma of unknown primary.
The University may submit one application. Preliminary proposals should be 1-2 pages in length and describe why the nominee deserves the award and what research will be performed during the award period. A curriculum vitae should also be included. If there are multiple applicants, the Masonic Cancer Center Executive Committee will name a committee of faculty members who will select the finalist to represent the University. Questions should be addressed to Mark Paller, Assistant Vice President for Research, AHC (palle001@umn.edu). Nominating materials should be sent via e-mail to Mary Sumpmann sumpm001@umn.edu ) before April 28, 2006. Additional information on the V Foundation can be found at their web site.
JOAN'S LEGACY STUDIES IN LUNG CANCER
The Joan Scarangello Foundation
Receipt deadline: June 30, 2006
Award: $50,000 per year for two years
Joan's Legacy invites grant applications for institutional research that studies lung cancer. The foundation is particularly interested in the genetic basis and biology of bronchoalveolar carcinoma as well as novel therapeutic approaches for the treatment of this disease. This funding is intended primarily as seed money for promising new work. It is not for supporting research where funding has either lapsed or has been previously disapproved. Preference will be given to applications where indirect costs are minimal or nonexistent. For further information, please see http://www.joanslegacy.org/Grant_app.html .
THE STICK IT TO CANCER WOMEN’S ICE HOCKEY TOURNAMENT
Do you enjoy hockey? Want to help raise money for the Masonic Cancer Center? The Stick it to Cancer Women's Ice Hockey Tournament will be April 21-23, 2006 at the Schwan Super Rink in Blaine. This 70-80 team hockey tournament with 1,000+ girls and women participating began eight years ago to raise funds for breast cancer research. Teams from Wisconsin , Michigan , North Dakota and Ontario , Canada come to participate. The Masonic Cancer Center has been selected to receive the proceeds this year. Last year they raised $36,000 for breast cancer research.
Approximately 100 volunteers are needed for the following positions: Ticket taker / ticket seller, referees, EMTs, score clocks and merchandise sales. If you would like to volunteer or want more information about the tournament, please contact Jackie at 763-792-7340 or jolson@superrink.org .
Click here for more information.
CANCER SUMMIT 2006: THE POWER OF COLLABORATION
Tuesday, April 25, 2006, 8 a.m.-5 p.m., Earl Brown Heritage Center, Brooklyn Center
The Minnesota Cancer Alliance will host the third annual Cancer Summit. Health care professionals, policymakers, advocates and survivors will come together to discuss the power of collaboration and the positive impact it can have on Minnesota's cancer burden.
Keynote speaker Tim Byers, M.D., M.P.H., University of Colorado Cancer Center, will explain how a comprehensive approach to cancer control has energized partners and has helped make Colorado a model for other states.
The Summit will feature an update on the latest Minnesota cancer data, skill-building workshops, roundtable discussions with cancer experts and working meetings of Alliance task forces. It will also include Combating Cancer in Your Community, a three-part mini-course designed to provide a basic cancer overview for community health workers, lay health workers and community volunteers who conduct health outreach work in various settings.
The Summit is open to anyone interested in learning about Minnesota cancer control efforts. Cancer Center members who wish to attend can fax (612-626-3069) or mail (MMC 806) their registration form to Jean Jacoby by the end of the day Thursday, April 13. Leave the payment method blank and Jean will submit the registration with payment. The registration form is available on the Minnesota Cancer Alliance Web site. Click on the Summit 2006 link, then on the registration form link, complete the form, print it, and send it to Jean (not to the contact listed on the form).
UNIVERSITY CHEMICAL-BIOLOGY INITIATIVE WORKSHOP MAY 17, 2006
Frontiers of Drug Discovery: Chemical Library Development and Screening
May 17, 2006, Coffman Memorial Union Theater
The aim of the workshop is to inform biomedical, pharmacological, medicinal, computational and chemical researchers at the University of Minnesota of recent advances in chemical library design and screening. An outstanding faculty has been assembled to present the latest cutting-edge chemical genetics research. Time will be made available during the workshop for questions and discussion, with the goal of fostering interdisciplinary research projects harnessing these techniques. Please join us! Click here to find out more and to register.
CHEMICAL BIOLOGY INTERFACE SYMPOSIUM JUNE 1, 2006
Mark your calendars for the Chemical Biology Interface Symposium, Thursday, June 1 at the St. Paul campus. The planning committee is putting together a program of speakers who work at the very cutting edge of science and pursue their research by combining different disciplinary approaches in chemistry, physics, molecular biology, and biochemistry. For more information about this event contact Larry Masterson, maste061@umn.edu 612-625-0786.